Showing results (41-50 of 62) with videos related to

Sort By:
Pageof 7
International Journal of Hematology|March 31, 2023
Severe systemic inflammation mimicking TAFRO syndrome following COVID-19Misato Tane, Hideki Kosako, Hiroki Hosoi, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|March 8, 2019
[Refractory ascites developing in late-phase of cord blood transplantation improving with CART]Takayuki Hiroi, Toshiki Mushino, Ken Tanaka, et al.
Internal Medicine (Tokyo, Japan)|November 23, 2022
Rituximab Monotherapy for Grade 2-3 Lymphomatoid Granulomatosis with Central Nervous System Involvement in a Patient Receiving Methotrexate for Rheumatoid ArthritisHiroki Hosoi, Ken Tanaka, Ayaka Sakaki, et al.
International Journal of Molecular Sciences|September 4, 2020
Targeting Adaptive IRE1α Signaling and PLK2 in Multiple Myeloma: Possible Anti-Tumor Mechanisms of KIRA8 and NilotinibYusuke Yamashita, Shuhei Morita, Hiroki Hosoi, et al.
Leukemia & Lymphoma|October 15, 2025
Genetic analysis of cell-free DNA in follicular lymphoma in comparison with tissue-derived DNAYoshikazu Hori, Hiroki Hosoi, Mitsuo Osuga, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|November 1, 2023
[Guillain-Barré syndrome associated with Epstein-Barr virus and cytomegalovirus reactivation during treatment for chronic graft-versus-host disease after allogeneic bone marrow transplantation]Hiroki Hosoi, Misato Tane, Hideki Kosako, et al.
Gene|January 14, 2021
Super-enhancers for RUNX3 are required for cell proliferation in EBV-infected B cell linesHiroki Hosoi, Akiko Niibori-Nambu, Giselle Sek Suan Nah, et al.
Computers in Biology and Medicine|June 19, 2024
Small sized centroblasts as poor prognostic factor in follicular lymphoma - Based on artificial intelligence analysisRyuta Iwamoto, Toui Nishikawa, Fidele Yambayamba Musangile, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|November 5, 2025
[Molecular targeted therapy for Erdheim-Chester disease]Makiko Sogabe, Shogo Murata, Ken Tanaka, et al.
Leukemia Research|January 23, 2017
An Epstein-Barr virus susceptible immature T-cell line, WILL4, established from a patient with T-lymphoblastic lymphoma bearing CD21 and a clonal EBV genomeHiroki Hosoi, Ken-Ichi Imadome, Shinobu Tamura, et al.
Pageof 7